Direct primary care for adults with heart failure pairs concierge-style physician access with a lab cadence tight enough to catch the weight and blood pressure swings that put heart failure patients back in the hospital. For this segment, the model only works if it treats weight, blood pressure, lipids, and inflammation as one connected system instead of a cardiology problem sitting apart from everything else.
TL;DR
- GoodLife Health's Cardiometabolic Optimization Membership tracks ApoB, Lp(a), hs-CRP and HbA1c every 90 days for heart failure patients.
- Direct primary care for heart failure works as a coordination layer alongside cardiology, not a replacement for it.
- The STEP-HFpEF trial (2023) found semaglutide improved heart failure symptom scores in patients with obesity and preserved ejection fraction.
- Same-week clinician access catches fluid retention and weight spikes before they become a 30-day readmission.
- GLP-1 therapy for heart failure patients is branded and FDA-approved only, never compounded.
- Cardiometabolic Optimization Membership runs a full lab panel (ApoB, Lp(a), hs-CRP, HbA1c) every 90 days for heart failure patients.
- Direct primary care coordinates weight, blood pressure, and medication management alongside cardiology - it doesn't replace it.
- STEP-HFpEF (2023) showed semaglutide improved heart failure symptom scores in patients with obesity and preserved ejection fraction.
- A 2-3 lb overnight weight gain is an early fluid-retention flag worth a same-week clinician message.
- GLP-1 prescribing stays branded and FDA-approved only, with no compounded versions used.
Why direct primary care matters for heart failure patients
Heart failure carries one of the highest 30-day hospital readmission rates of any chronic condition, and most of what triggers a readmission - fluid retention, a blood pressure spike, a missed medication interaction - shows up between visits, not during them. A once-a-year physical built around a standard insurance schedule was never designed to catch that gap. GoodLife Health's Cardiometabolic Optimization Membership treats weight, blood pressure, lipids, and inflammation as one interconnected system, because in a heart failure patient's body they move together - a rising HbA1c and a rising ApoB tend to show up in the same season, not one after the other.
A meaningful share of heart failure patients also carry a body mass index that qualifies for medical weight loss, particularly those with heart failure with preserved ejection fraction (HFpEF), a subtype closely tied to obesity and metabolic dysfunction. That overlap is exactly why a metabolic-first lens on heart failure care matters in 2026, not just a cardiac-first one.
Building a heart failure care plan around direct primary care
Track your weight and symptoms every day
This step costs nothing and it catches problems before a medication change is even needed.
- Weigh yourself at the same time each morning, same scale, before eating.
- Flag a 2-3 lb overnight gain immediately - it usually means fluid retention, not weight gain.
- Note new shortness of breath climbing stairs or lying flat.
- Track ankle and leg swelling changes week to week.
- Watch resting heart rate for unexplained increases.
Get a full cardiometabolic panel, not just a lipid check
Insurance-based primary care usually orders a basic lipid panel once a year, and that panel misses the markers that actually predict heart failure progression. Ask your current doctor for an expanded panel first - most insurance plans will cover ApoB and hs-CRP with the right diagnosis code. GoodLife Health's Biomarker Audit runs the full cardiometabolic panel every 90 days as part of the membership, so the labs don't wait for an annual visit to catch a change.
- Ask specifically for an ApoB lab test - it counts cholesterol-carrying particles directly instead of estimating from total cholesterol.
- Request Lp(a) once - it's largely genetic and typically only needs testing a single time.
- Track hs-CRP as a marker of vascular inflammation, not just cholesterol.
- Watch HbA1c even without a diabetes diagnosis - insulin resistance drives heart failure risk independent of blood sugar.
- Recheck lipids and inflammation markers every 90 days during any medication change or active weight loss, not just annually.
!Hub and spoke diagram showing five cardiometabolic lab markers connected to one central panel
Heart failure risk shows up across five interconnected markers, not one number.
Coordinate blood pressure control across every visit
Heart failure and high blood pressure are frequently managed by two different clinicians who never see the same chart, which is how a diuretic dose and an ACE inhibitor dose end up working against each other.
- Bring your home blood pressure log to every visit, not just office readings.
- Have one clinician reconcile every cardiac and blood pressure medication in a single review.
- Keep one shared medication list between your primary care clinician and your cardiologist.
- Take home readings twice daily during any medication change.
Review every medication for cardiac interactions
A heart failure diagnosis changes which over-the-counter drugs are safe, and most patients never get told that in a 15-minute visit.
- Flag NSAIDs like ibuprofen and naproxen - they worsen fluid retention in heart failure patients.
- Check diuretic dosing against your daily weight log, not on a fixed schedule alone.
- Confirm any new diabetes medication is heart-failure safe before starting it.
- Verify with your cardiologist before adding any new supplement or over-the-counter drug.
A heart failure diagnosis changes which over-the-counter drugs are safe - NSAIDs like ibuprofen and naproxen worsen fluid retention, and diuretic dosing should be checked against your daily weight log rather than a fixed schedule alone.
Ask whether GLP-1 therapy fits your heart failure profile
The STEP-HFpEF trial, published in 2023, found that semaglutide improved heart failure symptom scores in patients with obesity and preserved ejection fraction - a meaningful result for a subtype of heart failure closely tied to excess weight. That doesn't make GLP-1 therapy automatic for every heart failure diagnosis. It makes it a conversation worth having with a clinician who reads your labs before writing anything.
- Confirm your heart failure subtype (HFpEF vs. reduced ejection fraction) before assuming GLP-1 therapy applies.
- Ask for branded, FDA-approved medication only - GLP-1 medications for adults with heart failure covers Wegovy, Zepbound, Ozempic, and Mounjaro, never a compounded version.
- Get baseline labs, including kidney function, before starting.
- Expect slower, more closely monitored dose titration than in a patient without heart failure.
GoodLife Health prescribes GLP-1 medication under this rule with no exceptions: branded and FDA-approved only, billed at pharmacy cost with no markup on the medicine.
Confirm your heart failure subtype (HFpEF vs. reduced ejection fraction) before assuming GLP-1 therapy applies, and expect slower, more closely monitored dose titration than in a patient without heart failure.
Build a same-week escalation plan for symptom flares
Most heart failure hospitalizations start with a few days of worsening symptoms that a patient tries to manage alone before calling anyone.
- Set a personal threshold - a specific weight gain or symptom - that triggers a same-day message to your clinician.
- Confirm your membership includes same-week or same-day access, not a callback queue.
- Keep an updated medication and allergy list ready to share instantly.
- Know which symptoms mean call your clinician and which mean go to the emergency room.
Comparing care models for heart failure management
Comparing Care Models for Heart Failure Management
| Option | Best for | Monitoring cadence | Key limitation |
|---|---|---|---|
| Insurance-based primary care | Stable, low-complexity heart failure | Annual or biannual physical | Basic lipid panel only, limited same-week access |
| Cardiology-only follow-up | Cardiac function and device management | Every 3-6 months | Doesn't typically manage weight, hormones, or day-to-day symptom coaching |
| Telehealth chronic-care apps | Remote symptom logging without in-person labs | Continuous self-reported data | No blood draw, no ongoing physician relationship |
| GoodLife Health Cardiometabolic Optimization Membership | Heart failure patients tracking weight, lipids, inflammation, and blood pressure together | Biomarker Audit every 90 days plus ongoing access | Works alongside a cardiologist, not a replacement for cardiac specialty care |
For heart failure patients managing weight, blood pressure, and metabolic risk factors together in 2026, GoodLife Health's direct primary care membership works best as the coordination layer between cardiology visits, not a substitute for one.
Common mistakes heart failure patients make with direct primary care
- Treating heart failure as a cardiology-only problem and skipping metabolic labs like ApoB and HbA1c between cardiac visits.
- Waiting for symptoms to become severe before logging daily weight, instead of catching a 2-3 lb overnight gain early.
- Assuming a GLP-1 prescription is off the table with a heart failure diagnosis without asking a clinician who actually reads the labs.
- Letting two different doctors manage blood pressure medication without a shared list, creating dosing conflicts.
- Signing up for a telehealth chronic-care app that logs symptoms but never draws blood or examines a patient in real time.
FAQ
Can a direct primary care doctor manage heart failure?
A direct primary care clinician coordinates weight, blood pressure, lipids, and medication management for heart failure patients, but does not replace a cardiologist for device management or advanced cardiac imaging. It works best as a coordination layer alongside cardiology, not instead of it.
What labs should a heart failure patient get checked regularly?
ApoB, Lp(a), hs-CRP, HbA1c, and a full lipid panel are the core markers, checked roughly every 90 days if you're adjusting medication or losing weight. Lp(a) is largely genetic and usually only needs testing once.
Is GLP-1 medication safe for people with heart failure?
It depends on the heart failure subtype - the STEP-HFpEF trial (2023) found semaglutide improved symptoms in patients with obesity and preserved ejection fraction. It requires a clinician to review your labs and cardiac history before prescribing, and only branded, FDA-approved medication should be used.
How often should heart failure patients see a primary care clinician?
More often than an annual physical - same-week or same-day access matters because fluid retention and blood pressure changes can escalate within days. A direct primary care membership is built around that cadence; a standard insurance schedule usually is not.
What's the difference between direct primary care and cardiology follow-up?
Cardiology follow-up focuses on cardiac function, imaging, and device management every few months. Direct primary care handles the day-to-day: weight tracking, blood pressure coordination, medication review, and metabolic labs between cardiology visits.
Does direct primary care replace a cardiologist for heart failure?
No. It works alongside a cardiologist, handling ongoing monitoring and coordination while the cardiologist manages the cardiac-specific side of the diagnosis, such as ejection fraction and device therapy.
How much does a direct primary care membership cost in 2026?
GoodLife Health runs one flat monthly membership fee with a two-month starting commitment, then continues month-to-month with cancellation available after that. Check the site directly for current membership terms.
What is the Biomarker Audit and why does it matter for heart failure?
The Biomarker Audit is a comprehensive lab panel run every 90 days, covering ApoB, Lp(a), hs-CRP, HbA1c, and full hormone and thyroid panels. For heart failure patients, it catches metabolic shifts - like rising inflammation or insulin resistance - long before an annual physical would.
One last thing
The medication list is usually the most dangerous variable in heart failure care, not the diagnosis itself.
The medication list is usually the most dangerous variable in heart failure care, not the diagnosis itself - an NSAID picked up at a pharmacy counter can undo weeks of careful diuretic dosing. GoodLife Health's flat-fee model means the practice doesn't make more money if your GLP-1 dose escalates or if you end up on a fifth medication; the incentive lines up with fewer emergency visits, not more billable ones. That's Aligned Medicine in practice: the clinician's incentive matches your outcome, not your prescription count.
Related guides
- Lipid panel explained: what each number means for your heart
- Direct primary care for high blood pressure management
References
- Direct Primary Care: Practice Distribution and Cost Across the Nation (J Am Board Fam Med). 2015. pubmed.ncbi.nlm.nih.gov/26546651/